Contribution of Syncytins and Other Endogenous Retroviral Envelopes to Human Placenta Pathologies

Progress in Molecular Biology and Translational Science

Volumn 145, Issue , 2017, Pages 111-162

  Bolze, P A ^a,b   Mommert, M ^b,c   Mallet, F ^b,c  

^a UNIVERSITÉ LYON 1   (France)

^b CENTRE HOSPITALIER LYON SUD   (France)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Endogenous retrovirus; Placenta; Retroviral envelopes; Retrovirus; Syncytins

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; ENVELOPE PROTEIN; GLYCOPROTEIN; HISTONE; SYNCYTIN 1 PROTEIN; SYNCYTIN 2 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GCMA 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; PLACENTA PROTEIN; SYNCYTIN; VIRUS ENVELOPE PROTEIN;

ALTERNATIVE RNA SPLICING; APOPTOSIS; BREAST CANCER; CELL AGING; CELL DIFFERENTIATION; CELL FUSION; CELL PROLIFERATION; CYTOTOXICITY; CYTOTROPHOBLAST; DOWN SYNDROME; ENDOGENOUS RETROVIRUS; ENDOMETRIOSIS; ENDOMETRIUM CARCINOMA; ENVELOPE GENE; GENE LOCUS; GENETIC CODE; GENETIC SCREENING; GERM CELL TUMOR; HELLP SYNDROME; HISTONE METHYLATION; HUMAN; HUMAN GENOME; HYDATIDIFORM MOLE; IMMUNOMODULATION; INTRAUTERINE GROWTH RETARDATION; MAJOR GENE; NEUROTOXICITY; OVARY TUMOR; PLACENTA DEVELOPMENT; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; TESTIS TUMOR; TRANSCRIPTION REGULATION; TROPHOBLASTIC TUMOR; FEMALE; IMMUNOLOGY; METABOLISM; PATHOLOGY; PLACENTA; PREGNANCY;

ENDOGENOUS RETROVIRUSES; FEMALE; GENE PRODUCTS, ENV; GENETIC LOCI; HUMANS; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; VIRAL ENVELOPE PROTEINS;

EID: 85009448125     PISSN: 18771173     EISSN: 18780814     Source Type: Book Series    
DOI: 10.1016/bs.pmbts.2016.12.005     Document Type: Chapter

References (210)

1. 1 Brosius, J., Gould, S.J., On “genomenclature”: a comprehensive (and respectful) taxonomy for pseudogenes and other “junk DNA”. Proc Natl Acad Sci USA 89:22 (1992), 10706–10710.
2. 2 Brosius, J., Echoes from the past—are we still in an RNP world?. Cytogenet Genome Res 110:1–4 (2005), 8–24, 10.1159/000084934.
3. 3 Temin, H.M., Origin of retroviruses from cellular moveable genetic elements. Cell 21:3 (1980), 599–600.
4. 4 Lingner, J., Hughes, T.R., Shevchenko, A., Mann, M., Lundblad, V., Cech, T.R., Reverse transcriptase motifs in the catalytic subunit of telomerase. Science 276:5312 (1997), 561–567.
5. 5 Lower, R., Lower, J., Kurth, R., The viruses in all of us: characteristics and biological significance of human endogenous retrovirus sequences. Proc Natl Acad Sci USA 93:11 (1996), 5177–5184.
6. 6 Malik, H.S., Henikoff, S., Eickbush, T.H., Poised for contagion: evolutionary origins of the infectious abilities of invertebrate retroviruses. Genome Res 10:9 (2000), 1307–1318.
7. 7 Kim, F.J., Battini, J.-L., Manel, N., Sitbon, M., Emergence of vertebrate retroviruses and envelope capture. Virology 318:1 (2004), 183–191, 10.1016/j.virol.2003.09.026.
8. 8 Coffin, J.M., Hughes, S.H., Varmus, H.E., Boeke, J.D., Stoye, J.P., Retrotransposons, Endogenous Retroviruses, and the Evolution of Retroelements. 1997, Cold Spring Harbor Laboratory Press, New York, NY.
9. 9 Lander, E.S., Linton, L.M., Birren, B., et al. Initial sequencing and analysis of the human genome. Nature 409:6822 (2001), 860–921.
10. 10 Kalter, S.S., Heberling, R.L., Helmke, R.J., et al. A comparative study on the presence of C-type viral particles in placentas from primates and other animals. Bibl Haematol 40 (1975), 391–401.
11. 11 Lyden, T.W., Johnson, P.M., Mwenda, J.M., Rote, N.S., Ultrastructural characterization of endogenous retroviral particles isolated from normal human placentas. Biol Reprod 51:1 (1994), 152–157.
12. 12 Venables, P.J., Brookes, S.M., Griffiths, D., Weiss, R.A., Boyd, M.T., Abundance of an endogenous retroviral envelope protein in placental trophoblasts suggests a biological function. Virology 211:2 (1995), 589–592.
13. 13 Langat, D.K., Johnson, P.M., Rote, N.S., et al. Characterization of antigens expressed in normal baboon trophoblast and cross-reactive with HIV/SIV antibodies. J Reprod Immunol 42:1 (1999), 41–58.
14. 14 Ruebner, M., Strissel, P.L., Ekici, A.B., et al. Reduced syncytin-1 expression levels in placental syndromes correlates with epigenetic hypermethylation of the ERVW-1 promoter region. PLoS One, 8(2), 2013, e56145, 10.1371/journal.pone.0056145.
15. 15 Mühle, M., Kroniger, T., Hoffmann, K., Denner, J., The immunosuppressive domain of the transmembrane envelope protein gp41 of HIV-1 binds to human monocytes and B cells. Immunol Res 64:3 (2016), 721–729, 10.1007/s12026-015-8776-4.
16. 16 Douville, R.N., Hiscott, J., The interface between the innate interferon response and expression of host retroviral restriction factors. Cytokine 52:1–2 (2010), 108–115, 10.1016/j.cyto.2010.04.010.
17. 17 Goodier, J.L., Restricting retrotransposons: a review. Mob DNA, 7(1), 2016, 16, 10.1186/s13100-016-0070-z.
18. 18 Blikstad, V., Benachenhou, F., Sperber, G.O., Blomberg, J., Evolution of human endogenous retroviral sequences: a conceptual account. Cell Mol Life Sci 65:21 (2008), 3348–3365, 10.1007/s00018-008-8495-2.
19. 19 Beimforde, N., Hanke, K., Ammar, I., Kurth, R., Bannert, N., Molecular cloning and functional characterization of the human endogenous retrovirus K113. Virology 371:1 (2008), 216–225.
20. 20 Boller, K., Schonfeld, K., Lischer, S., et al. Human endogenous retrovirus HERV-K113 is capable of producing intact viral particles. J Gen Virol 89:pt 2 (2008), 567–572.
21. 21 Contreras-Galindo, R., Kaplan, M.H., Leissner, P., et al. Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer. J Virol 82:19 (2008), 9329–9336, 10.1128/JVI.00646-08.
22. 22 Subramanian, R.P., Wildschutte, J.H., Russo, C., Coffin, J.M., Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses. Retrovirology, 8(1), 2011, 90, 10.1186/1742-4690-8-90.
23. 23 Gifford, R., Tristem, M., The evolution, distribution and diversity of endogenous retroviruses. Virus Genes 26:3 (2003), 291–315.
24. 24 Lavie, L., Medstrand, P., Schempp, W., Meese, E., Mayer, J., Human endogenous retrovirus family HERV-K(HML-5): status, evolution, and reconstruction of an ancient betaretrovirus in the human genome. J Virol 78:16 (2004), 8788–8798, 10.1128/JVI.78.16.8788-8798.2004.
25. 25 van Regenmortel, M.H., Mayo, M.A., Fauquet, C.M., Maniloff, J., Virus nomenclature: consensus versus chaos. Arch Virol 145 (2000), 2227–2232.
26. 26 Coffin, J.M., Genetic diversity and evolution of retroviruses. Curr Top Microbiol Immunol 176 (1992), 143–164.
27. 27 Benit, L., Lallemand, J.B., Casella, J.F., Philippe, H., Heidmann, T., ERV-L elements: a family of endogenous retrovirus-like elements active throughout the evolution of mammals. J Virol 73:4 (1999), 3301–3308.
28. 28 Belshaw, R., Katzourakis, A., Paces, J., Burt, A., Tristem, M., High copy number in human endogenous retrovirus families is associated with copying mechanisms in addition to reinfection. Mol Biol Evol 22:4 (2005), 814–817.
29. 29 Benit, L., Dessen, P., Heidmann, T., Identification, phylogeny, and evolution of retroviral elements based on their envelope genes. J Virol 75:23 (2001), 11709–11719.
30. 30 Jurka, J., Kapitonov, V.V., Pavlicek, A., Klonowski, P., Kohany, O., Walichiewicz, J., Repbase Update, a database of eukaryotic repetitive elements. Cytogenet Genome Res 110:1–4 (2005), 462–467, 10.1159/000084979.
31. 31 Mager, D.L., Medstrand, P., Retroviral repeat sequences. Cooper, D., (eds.) Nature Encyclopedia of the Human Genome, vol 5, 2003, Nature Publishing Group, Hampshire, England, 57–63.
32. 32 Tempel, S., Jurka, M., Jurka, J., VisualRepbase: an interface for the study of occurrences of transposable element families. BMC Bioinf, 9(1), 2008, 345, 10.1186/1471-2105-9-345.
33. 33 Tristem, M., Identification and characterization of novel human endogenous retrovirus families by phylogenetic screening of the human genome mapping project database. J Virol 74:8 (2000), 3715–3730.
34. 34 Hughes, J.F., Coffin, J.M., Evidence for genomic rearrangements mediated by human endogenous retroviruses during primate evolution. Nat Genet 29:4 (2001), 487–489, 10.1038/ng775.
35. 35 Blanco, P., Shlumukova, M., Sargent, C.A., Jobling, M.A., Affara, N., Hurles, M.E., Divergent outcomes of intrachromosomal recombination on the human Y chromosome: male infertility and recurrent polymorphism. J Med Genet 37:10 (2000), 752–758.
36. 36 Kamp, C., Hirschmann, P., Voss, H., Huellen, K., Vogt, P.H., Two long homologous retroviral sequence blocks in proximal Yq11 cause AZFa microdeletions as a result of intrachromosomal recombination events. Hum Mol Genet 9:17 (2000), 2563–2572.
37. 37 Sun, C., Skaletsky, H., Rozen, S., et al. Deletion of azoospermia factor a (AZFa) region of human Y chromosome caused by recombination between HERV15 proviruses. Hum Mol Genet 9:15 (2000), 2291–2296.
38. 38 Cohen, C.J., Lock, W.M., Mager, D.L., Endogenous retroviral LTRs as promoters for human genes: a critical assessment. Gene 448 (2009), 105–114.
39. 39 Long, Q., Bengra, C., Li, C., Kutlar, F., Tuan, D., A long terminal repeat of the human endogenous retrovirus ERV-9 is located in the 5′ boundary area of the human beta-globin locus control region. Genomics 54:3 (1998), 542–555, 10.1006/geno.1998.5608.
40. 40 Schulte, A.M., Lai, S., Kurtz, A., Czubayko, F., Riegel, A.T., Wellstein, A., Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus. Proc Natl Acad Sci USA 93:25 (1996), 14759–14764.
41. 41 Ting, C.N., Rosenberg, M.P., Snow, C.M., Samuelson, L.C., Meisler, M.H., Endogenous retroviral sequences are required for tissue-specific expression of a human salivary amylase gene. Genes Dev 6:8 (1992), 1457–1465.
42. 42 Blond, J.-L., Lavillette, D., Cheynet, V., et al. An envelope glycoprotein of the human endogenous retrovirus HERV-W is expressed in the human placenta and fuses cells expressing the type D mammalian retrovirus receptor. J Virol 74:7 (2000), 3321–3329.
43. 43 Boese, A., Sauter, M., Galli, U., et al. Human endogenous retrovirus protein cORF supports cell transformation and associates with the promyelocytic leukemia zinc finger protein. Oncogene 19:38 (2000), 4328–4336.
44. 44 Magin, C., Lower, R., Lower, J., cORF and RcRE, the Rev/Rex and RRE/RxRE homologues of the human endogenous retrovirus family HTDV/HERV-K. J Virol 73:11 (1999), 9496–9507.
45. 45 Mangeney, M., Renard, M., Schlecht-Louf, G., et al. Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins. Proc Natl Acad Sci USA 104:51 (2007), 20534–20539 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18077339.
46. 46 de Parseval, N., Lazar, V., Casella, J.F., Benit, L., Heidmann, T., Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins. J Virol 77:19 (2003), 10414–10422, 10.1128/JVI.77.19.10414-10422.2003.
47. 47 Villesen, P., Aagaard, L., Wiuf, C., Pedersen, F.S., Identification of endogenous retroviral reading frames in the human genome. Retrovirology, 1, 2004, 32.
48. 48 Roebke, C., Wahl, S., Laufer, G., et al. An N-terminally truncated envelope protein encoded by a human endogenous retrovirus W locus on chromosome Xq22.3. Retrovirology, 7(1), 2010, 69, 10.1186/1742-4690-7-69.
49. 49 Nellaker, C., Yao, Y., Jones-Brando, L., Mallet, F., Yolken, R.H., Karlsson, H., Transactivation of elements in the human endogenous retrovirus W family by viral infection. Retrovirology, 3, 2006, 44, 10.1186/1742-4690-3-44.
50. 50 Laufer, G., Mayer, J., Mueller, B.F., Mueller-Lantzsch, N., Ruprecht, K., Analysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequences. Retrovirology, 6, 2009, 37.
51. 51 Schmitt, K., Richter, C., Backes, C., Meese, E., Ruprecht, K., Mayer, J., Comprehensive analysis of human endogenous retrovirus group HERV-W locus transcription in multiple sclerosis brain lesions by high-throughput amplicon sequencing. J Virol 87:24 (2013), 13837–13852, 10.1128/JVI.02388-13.
52. 52 Mayer, J., Blomberg, J., Seal, R.L., A revised nomenclature for transcribed human endogenous retroviral loci. Mob DNA, 2(1), 2011, 7, 10.1186/1759-8753-2-7.
53. 53 Blaise, S., de Parseval, N., Heidmann, T., Functional characterization of two newly identified Human Endogenous Retrovirus coding envelope genes. Retrovirology, 2, 2005, 19.
54. 54 de Parseval, N., Casella, J., Gressin, L., Heidmann, T., Characterization of the three HERV-H proviruses with an open envelope reading frame encompassing the immunosuppressive domain and evolutionary history in primates. Virology 279:2 (2001), 558–569, 10.1006/viro.2000.0737.
55. 55 Andersson, A.C., Merza, M., Venables, P., et al. Elevated levels of the endogenous retrovirus ERV3 in human sebaceous glands. J Invest Dermatol 106:1 (1996), 125–128.
56. 56 Andersson, A.C., Yun, Z., Sperber, G.O., Larsson, E., Blomberg, J., ERV3 and related sequences in humans: structure and RNA expression. J Virol 79:14 (2005), 9270–9284.
57. 57 Cohen, M., Powers, M., O'Connell, C., Kato, N., The nucleotide sequence of the env gene from the human provirus ERV3 and isolation and characterization of an ERV3-specific cDNA. Virology 147:2 (1985), 449–458.
58. 58 Cohen, M., Kato, N., Larsson, E., ERV3 human endogenous provirus mRNAs are expressed in normal and malignant tissues and cells, but not in choriocarcinoma tumor cells. J Cell Biochem 36:2 (1988), 121–128, 10.1002/jcb.240360203.
59. 59 Kato, N., Pfeifer-Ohlsson, S., Kato, M., et al. Tissue-specific expression of human provirus ERV3 mRNA in human placenta: two of the three ERV3 mRNAs contain human cellular sequences. J Virol 61:7 (1987), 2182–2191.
60. 60 Larsson, E., Andersson, A.C., Nilsson, B.O., Expression of an endogenous retrovirus (ERV3 HERV-R) in human reproductive and embryonic tissues—evidence for a function for envelope gene products. Ups J Med Sci 99:2 (1994), 113–120.
61. 61 Malassiné, A., Blaise, S., Handschuh, K., et al. Expression of the fusogenic HERV-FRD Env glycoprotein (syncytin 2) in human placenta is restricted to villous cytotrophoblastic cells. Placenta 28:2–3 (2007), 185–191, 10.1016/j.placenta.2006.03.001.
62. 62 Blaise, S., de Parseval, N., Bénit, L., Heidmann, T., Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution. Proc Natl Acad Sci USA 100:22 (2003), 13013–13018, 10.1073/pnas.2132646100.
63. 63 Chen, C.P., Chen, L.F., Yang, S.R., et al. Functional characterization of the human placental fusogenic membrane protein syncytin 2. Biol Reprod 79:5 (2008), 815–823.
64. 64 Dewannieux, M., Blaise, S., Heidmann, T., Identification of a functional envelope protein from the HERV-K family of human endogenous retroviruses. J Virol 79:24 (2005), 15573–15577.
65. 65 Tonjes, R.R., Czauderna, F., Kurth, R., Genome-wide screening, cloning, chromosomal assignment, and expression of full-length human endogenous retrovirus type K. J Virol 73:11 (1999), 9187–9195.
66. 66 Barbulescu, M., Turner, G., Seaman, M.I., Deinard, A.S., Kidd, K.K., Lenz, J., Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. Curr Biol 9:16 (1999), 861–868.
67. 67 Turner, G., Barbulescu, M., Su, M., Jensen-Seaman, M.I., Kidd, K.K., Lenz, J., Insertional polymorphisms of full-length endogenous retroviruses in humans. Curr Biol 11:19 (2001), 1531–1535.
68. 68 Vargas, A., Toufaily, C., LeBellego, F., Rassart, É., Lafond, J., Barbeau, B., Reduced expression of both syncytin 1 and syncytin 2 correlates with severity of preeclampsia. Reprod Sci 18:11 (2011), 1085–1091, 10.1177/1933719111404608.
69. 69 Kjeldbjerg, A.L., Villesen, P., Aagaard, L., Pedersen, F.S., Gene conversion and purifying selection of a placenta-specific ERV-V envelope gene during simian evolution. BMC Evol Biol, 8(1), 2008, 266, 10.1186/1471-2148-8-266.
70. 70 Blond, J.L., Beseme, F., Duret, L., et al. Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family. J Virol 73:2 (1999), 1175–1185.
71. 71 Frendo, J.L., Olivier, D., Cheynet, V., et al. Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation. Mol Cell Biol 23:10 (2003), 3566–3574.
72. 72 Pérot, P., Bolze, P.A., Mallet, F., From viruses to genes: syncytins. Witzany, G., (eds.) Viruses: Essential Agents of Life, 2012, Springer Science + Business Media, Dordrecht, Netherlands, 325–361, 10.1007/978-94-007-4899-6_17 [chapter 17].
73. 73 Henzy, J.E., Coffin, J.M., Betaretroviral envelope subunits are noncovalently associated and restricted to the mammalian class. J Virol 87:4 (2013), 1937–1946, 10.1128/JVI.01442-12.
74. 74 Cheynet, V., Ruggieri, A., Oriol, G., et al. Synthesis, assembly, and processing of the Env ERVWE1/syncytin human endogenous retroviral envelope. J Virol 79:9 (2005), 5585–5593, 10.1128/JVI.79.9.5585-5593.2005.
75. 75 Vargas, A., Thiery, M., Lafond, J., Barbeau, B., Transcriptional and functional studies of Human Endogenous Retrovirus envelope EnvP(b) and EnvV genes in human trophoblasts. Virology 425:1 (2012), 1–10, 10.1016/j.virol.2011.12.015.
76. 76 Lavillette, D., Marin, M., Ruggieri, A., Mallet, F., Cosset, F.L., Kabat, D., The envelope glycoprotein of human endogenous retrovirus type W uses a divergent family of amino acid transporters/cell surface receptors. J Virol 76:13 (2002), 6442–6452.
77. 77 Esnault, C., Priet, S., Ribet, D., et al. A placenta-specific receptor for the fusogenic, endogenous retrovirus-derived, human syncytin-2. Proc Natl Acad Sci USA 105:45 (2008), 17532–17537.
78. 78 Mangeney, M., Heidmann, T., Tumor cells expressing a retroviral envelope escape immune rejection in vivo. Proc Natl Acad Sci USA 95:25 (1998), 14920–14925.
79. 79 Tolosa, J.M., Schjenken, J.E., Clifton, V.L., et al. The endogenous retroviral envelope protein syncytin-1 inhibits LPS/PHA-stimulated cytokine responses in human blood and is sorted into placental exosomes. Placenta 33:11 (2012), 933–941, 10.1016/j.placenta.2012.08.004.
80. 80 Lavialle, C., Cornelis, G., Dupressoir, A., et al. Paleovirology of “syncytins”, retroviral env genes exapted for a role in placentation. Philos Trans R Soc B, 368(1626), 2013, 20120507, 10.1098/rstb.2012.0507.
81. 81 Umehara, D., Kawamura, M., Odahara, Y., et al. Role of N-terminal sequences of the tyrosine kinase sf-Stk in transformation of rodent fibroblasts by variants of Friend spleen focus-forming virus. Int J Cancer 131:5 (2012), 1083–1094, 10.1002/ijc.27330.
82. 82 Feldman, D., Roniger, M., Bar-Sinai, A., et al. The signal peptide of mouse mammary tumor virus-env: a phosphoprotein tumor modulator. Mol Cancer Res 10:8 (2012), 1077–1086, 10.1158/1541-7786.MCR-11-0581.
83. 83 Hull, S., Lim, J., Hamil, A., Nitta, T., Fan, H., Analysis of jaagsiekte sheep retrovirus (JSRV) envelope protein domains in transformation. Virus Genes 45:3 (2012), 508–517, 10.1007/s11262-012-0793-y.
84. 84 Zhao, J., Rycaj, K., Geng, S., et al. Expression of human endogenous retrovirus type K envelope protein is a novel candidate prognostic marker for human breast cancer. Genes Cancer 2:9 (2011), 914–922, 10.1177/1947601911431841.
85. 85 Januszkiewicz-Lewandowska, D., Nowicka, K., Rembowska, J., et al. Env gene expression of human endogenous retrovirus-k and human endogenous retrovirus-w in childhood acute leukemia cells. Acta Haematol 129:4 (2013), 232–237, 10.1159/000345407.
86. 86 Krone, B., Grange, J.M., Melanoma, Darwinian medicine and the inner world. J Cancer Res Clin Oncol 136:12 (2010), 1787–1794, 10.1007/s00432-010-0949-x.
87. 87 Mullins, C.S., Linnebacher, M., Human endogenous retroviruses and cancer: causality and therapeutic possibilities. World J Gastroenterol 18:42 (2012), 6027–6035, 10.3748/wjg.v18.i42.6027.
88. 88 Mi, S., Lee, X., Li, X., et al. Syncytin is a captive retroviral envelope protein involved in human placental morphogenesis. Nature 403:6771 (2000), 785–789, 10.1038/35001608.
89. 89 Lee, X., Keith, J.C. Jr., Stumm, N., et al. Downregulation of placental syncytin expression and abnormal protein localization in pre-eclampsia. Placenta 22:10 (2001), 808–812, 10.1053/plac.2001.0722.
90. 90 Chen, C.P., Wang, K.G., Chen, C.Y., Yu, C., Chuang, H.C., Chen, H., Altered placental syncytin and its receptor ASCT2 expression in placental development and pre-eclampsia. BJOG 113:2 (2006), 152–158, 10.1111/j.1471-0528.2005.00843.x.
91. 91 Langbein, M., Strick, R., Strissel, P.L., et al. Impaired cytotrophoblast cell–cell fusion is associated with reduced Syncytin and increased apoptosis in patients with placental dysfunction. Mol Reprod Dev 75:1 (2007), 175–183, 10.1002/mrd.20729.
92. 92 Pathirage, N.A., Cocquebert, M., Sadovsky, Y., et al. Homeobox gene transforming growth factor β-induced factor-1 (TGIF-1) is a regulator of villous trophoblast differentiation and its expression is increased in human idiopathic fetal growth restriction. Mol Hum Reprod 19:10 (2013), 665–675, 10.1093/molehr/gat042.
93. 93 Vargas, A., Zhou, S., Ethier-Chiasson, M., et al. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia. FASEB J 28:8 (2014), 3703–3719, 10.1096/fj.13-239053.
94. 94 Bjerregard, B., Ziomkiewicz, I., Schulz, A., Larsson, L.-I., Syncytin-1 in differentiating human myoblasts: relationship to caveolin-3 and myogenin. Cell Tissue Res 357:1 (2014), 355–362, 10.1007/s00441-014-1930-9.
95. 95 Oluwole, S.O., Yao, Y., Conradi, S., Kristensson, K., Karlsson, H., Elevated levels of transcripts encoding a human retroviral envelope protein (syncytin) in muscles from patients with motor neuron disease. Amyotroph Lateral Scler 8:2 (2007), 67–72.
96. 96 Redelsperger, F., Raddi, N., Bacquin, A., et al. Genetic evidence that captured retroviral envelope syncytins contribute to myoblast fusion and muscle sexual dimorphism in mice. PLoS Genet, 12(9), 2016, e1006289, 10.1371/journal.pgen.1006289.
97. 97 Søe, K., Andersen, T.L., Hobolt-Pedersen, A.-S., Bjerregaard, B., Larsson, L.-I., Delaissé, J.-M., Involvement of human endogenous retroviral syncytin-1 in human osteoclast fusion. Bone 48:4 (2011), 837–846, 10.1016/j.bone.2010.11.011.
98. 98 Hobolt-Pedersen, A.-S., Delaissé, J.-M., Søe, K., Osteoclast fusion is based on heterogeneity between fusion partners. Calcif Tissue Int 95:1 (2014), 73–82, 10.1007/s00223-014-9864-5.
99. 99 Bjerregaard, B., Lemmen, J.G., Petersen, M.R., et al. Syncytin-1 and its receptor is present in human gametes. J Assist Reprod Genet 31:5 (2014), 533–539, 10.1007/s10815-014-0224-1.
100. 100 Bjerregaard, B., Holck, S., Christensen, I.J., Larsson, L.I., Syncytin is involved in breast cancer-endothelial cell fusions. Cell Mol Life Sci 63:16 (2006), 1906–1911, 10.1007/s00018-006-6201-9.
101. 101 Strick, R., Ackermann, S., Langbein, M., et al. Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral Syncytin-1 and regulated by TGF-beta. J Mol Med (Berl) 85:1 (2007), 23–38, 10.1007/s00109-006-0104-y.
102. 102 Mo, H., Ouyang, D., Xu, L., Gao, Q., He, X., Human endogenous retroviral syncytin exerts inhibitory effect on invasive phenotype of B16F10 melanoma cells. Chin J Cancer Res 25:5 (2013), 556–564, 10.3978/j.issn.1000-9604.2013.10.06.
103. 103 Knerr, I., Schnare, M., Hermann, K., et al. Fusiogenic endogenous-retroviral syncytin-1 exerts anti-apoptotic functions in staurosporine-challenged CHO cells. Apoptosis 12:1 (2007), 37–43, 10.1007/s10495-006-0329-9.
104. 104 Huang, Q., Chen, H., Li, J., et al. Epigenetic and non-epigenetic regulation of syncytin-1 expression in human placenta and cancer tissues. Cell Signal 26:3 (2014), 648–656, 10.1016/j.cellsig.2013.11.002.
105. 105 Chuprin, A., Gal, H., Biron-Shental, T., et al. Cell fusion induced by ERVWE1 or measles virus causes cellular senescence. Genes Dev 27:21 (2013), 2356–2366, 10.1101/gad.227512.113.
106. 106 Holder, B.S., Tower, C.L., Forbes, K., Mulla, M.J., Aplin, J.D., Abrahams, V.M., Immune cell activation by trophoblast-derived microvesicles is mediated by syncytin 1. Immunology 136:2 (2012), 184–191, 10.1111/j.1365-2567.2012.03568.x.
107. 107 Antony, J.M., Ellestad, K.K., Hammond, R., et al. The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes. J Immunol 179:2 (2007), 1210–1224.
108. 108 Antony, J.M., van Marle, G., Opii, W., et al. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat Neurosci 7:10 (2004), 1088–1095, 10.1038/nn1319.
109. 109 Kremer, D., Schichel, T., Förster, M., et al. Human endogenous retrovirus type W envelope protein inhibits oligodendroglial precursor cell differentiation. Ann Neurol 74:5 (2013), 721–732, 10.1002/ana.23970.
110. 110 Perron, H., Mekaoui, L., Bernard, C., Veas, F., Stefas, I., Leboyer, M., Endogenous retrovirus type W GAG and envelope protein antigenemia in serum of schizophrenic patients. Biol Psychiatry 64:12 (2008), 1019–1023.
111. 111 Voisset, C., Bouton, O., Bedin, F., et al. Chromosomal distribution and coding capacity of the human endogenous retrovirus HERV-W family. AIDS Res Hum Retrovir 16:8 (2000), 731–740.
112. 112 Prudhomme, S., Oriol, G., Mallet, F., A retroviral promoter and a cellular enhancer define a bipartite element which controls env ERVWE1 placental expression. J Virol 78:22 (2004), 12157–12168, 10.1128/JVI.78.22.12157-12168.2004.
113. 113 Vargas, A., Moreau, J., Landry, S., et al. Syncytin-2 plays an important role in the fusion of human trophoblast cells. J Mol Biol 392:2 (2009), 301–318.
114. 114 Toufaily, C., Vargas, A., Lemire, M., Lafond, J., Rassart, E., Barbeau, B., MFSD2a, the Syncytin-2 receptor, is important for trophoblast fusion. Placenta 34:1 (2013), 85–88, 10.1016/j.placenta.2012.10.012.
115. 115 Lin, L., Xu, B., Rote, N.S., Expression of endogenous retrovirus ERV-3 induces differentiation in BeWo, a choriocarcinoma model of human placental trophoblast. Placenta 20:1 (1999), 109–118.
116. 116 Lin, L., Xu, B., Rote, N.S., The cellular mechanism by which the human endogenous retrovirus ERV-3 env gene affects proliferation and differentiation in a human placental trophoblast model, BeWo. Placenta 21:1 (2000), 73–78.
117. 117 de Parseval, N., Heidmann, T., Physiological knockout of the envelope gene of the single-copy ERV-3 human endogenous retrovirus in a fraction of the Caucasian population. J Virol 72:4 (1998), 3442–3445.
118. 118 Dupressoir, A., Marceau, G., Vernochet, C., et al. Syncytin-A and syncytin-B, two fusogenic placenta-specific murine envelope genes of retroviral origin conserved in Muridae. Proc Natl Acad Sci USA 102:3 (2005), 725–730.
119. 119 Dupressoir, A., Vernochet, C., Harper, F., et al. A pair of co-opted retroviral envelope syncytin genes is required for formation of the two-layered murine placental syncytiotrophoblast. Proc Natl Acad Sci USA 108:46 (2011), E1164–E1173, 10.1073/pnas.1112304108.
120. 120 Cornelis, G., Vernochet, C., Carradec, Q., et al. Retroviral envelope gene captures and syncytin exaptation for placentation in marsupials. Proc Natl Acad Sci USA 112:5 (2015), E487–E496, 10.1073/pnas.1417000112.
121. 121 Smallwood, A., Temporal regulation of the expression of syncytin (HERV-W), maternally imprinted PEG10, and SGCE in human placenta. Biol Reprod 69:1 (2003), 286–293, 10.1095/biolreprod.102.013078.
122. 122 Gimenez, J., Montgiraud, C., Pichon, J.-P., et al. Custom human endogenous retroviruses dedicated microarray identifies self-induced HERV-W family elements reactivated in testicular cancer upon methylation control. Nucleic Acids Res 38:7 (2010), 2229–2246, 10.1093/nar/gkp1214.
123. 123 Trejbalová, K., Blazková, J., Matousková, M., et al. Epigenetic regulation of transcription and splicing of syncytins, fusogenic glycoproteins of retroviral origin. Nucleic Acids Res 39:20 (2011), 8728–8739, 10.1093/nar/gkr562.
124. 124 Li, F., Nellaker, C., Sabunciyan, S., et al. Transcriptional derepression of the ERVWE1 locus following influenza A virus infection. J Virol 88:8 (2014), 4328–4337, 10.1128/JVI.03628-13.
125. 125 Gimenez, J., Montgiraud, C., Oriol, G., et al. Comparative methylation of ERVWE1/syncytin-1 and other human endogenous retrovirus LTRs in placenta tissues. DNA Res 16:4 (2009), 195–211, 10.1093/dnares/dsp011.
126. 126 Matouskova, M., Blazkova, J., Pajer, P., Pavlicek, A., Hejnar, J., CpG methylation suppresses transcriptional activity of human syncytin-1 in non-placental tissues. Exp Cell Res 312:7 (2006), 1011–1020.
127. 127 Chen, Y.X., Allars, M., Maiti, K., et al. Factors affecting cytotrophoblast cell viability and differentiation: evidence of a link between syncytialisation and apoptosis. Int J Biochem Cell Biol 43:5 (2011), 821–828, 10.1016/j.biocel.2011.02.007.
128. 128 Ruebner, M., Langbein, M., Strissel, P.L., et al. Regulation of the human endogenous retroviral Syncytin-1 and cell-cell fusion by the nuclear hormone receptors PPARγ/RXRα in placentogenesis. J Cell Biochem 113:7 (2012), 2383–2396, 10.1002/jcb.24110.
129. 129 Mameli, G., Astone, V., Khalili, K., Serra, C., Sawaya, B.E., Dolei, A., Regulation of the syncytin-1 promoter in human astrocytes by multiple sclerosis-related cytokines. Virology 362:1 (2007), 120–130, 10.1016/j.virol.2006.12.019.
130. 130 Basyuk, E., Cross, J.C., Corbin, J., et al. Murine Gcm1 gene is expressed in a subset of placental trophoblast cells. Dev Dyn 214:4 (1999), 303–311, 10.1002/(SICI)1097-0177(199904)214:4<303::AID-AJA3>3.0.CO;2-B.
131. 131 Janatpour, M.J., Utset, M.F., Cross, J.C., et al. A repertoire of differentially expressed transcription factors that offers insight into mechanisms of human cytotrophoblast differentiation. Dev Genet 25:2 (1999), 146–157, 10.1002/(SICI)1520-6408(1999)25:2<146::AID-DVG9>3.0.CO;2-K.
132. 132 Yu, C., Shen, K., Lin, M., et al. GCMa regulates the syncytin-mediated trophoblastic fusion. J Biol Chem 277:51 (2002), 50062–50068.
133. 133 Liang, C.-Y., Wang, L.-J., Chen, C.-P., Chen, L.-F., Chen, Y.-H., Chen, H., GCM1 regulation of the expression of syncytin 2 and its cognate receptor MFSD2A in human placenta. Biol Reprod 83:3 (2010), 387–395, 10.1095/biolreprod.110.083915.
134. 134 Chang, C.-W., Chuang, H.-C., Yu, C., Yao, T.-P., Chen, H., Stimulation of GCMa transcriptional activity by cyclic AMP/protein kinase A signaling is attributed to CBP-mediated acetylation of GCMa. Mol Cell Biol 25:19 (2005), 8401–8414, 10.1128/MCB.25.19.8401-8414.2005.
135. 135 Knerr, I., Schubert, S.W., Wich, C., et al. Stimulation of GCMa and syncytin via cAMP mediated PKA signaling in human trophoblastic cells under normoxic and hypoxic conditions. FEBS Lett 579:18 (2005), 3991–3998, 10.1016/j.febslet.2005.06.029.
136. 136 Klase, Z., Winograd, R., Davis, J., et al. HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology, 6, 2009, 18.
137. 137 Schubert, S.W., Lamoureux, N., Kilian, K., Klein-Hitpass, L., Hashemolhosseini, S., Identification of integrin-alpha4, Rb1, and syncytin a as murine placental target genes of the transcription factor GCMa/Gcm1. J Biol Chem 283:9 (2008), 5460–5465.
138. 138 Baczyk, D., Drewlo, S., Proctor, L., Dunk, C., Lye, S., Kingdom, J., Glial cell missing-1 transcription factor is required for the differentiation of the human trophoblast. Cell Death Differ 16:5 (2009), 719–727, 10.1038/cdd.2009.1.
139. 139 Wilson, M.L., Brueggmann, D., Desmond, D.H., Mandeville, J.E., Goodwin, T.M., Ingles, S.A., A fetal variant in the GCM1 gene is associated with pregnancy induced hypertension in a predominantly hispanic population. Int J Mol Epidemiol Genet 2:3 (2011), 196–206.
140. 140 Muroi, Y., Sakurai, T., Hanashi, A., Kubota, K., Nagaoka, K., Imakawa, K., CD9 regulates transcription factor GCM1 and ERVWE1 expression through the cAMP/protein kinase A signaling pathway. Reproduction 138:6 (2009), 945–951, 10.1530/REP-09-0082.
141. 141 Li, F., Karlsson, H., Expression and regulation of human endogenous retrovirus W elements. APMIS 124:1–2 (2016), 52–66, 10.1111/apm.12478.
142. 142 Cheynet, V., Oriol, G., Mallet, F., Identification of the hASCT2-binding domain of the Env ERVWE1/syncytin-1 fusogenic glycoprotein. Retrovirology, 3, 2006, 41, 10.1186/1742-4690-3-41.
143. 143 Bonnaud, B., Bouton, O., Oriol, G., Cheynet, V., Duret, L., Mallet, F., Evidence of selection on the domesticated ERVWE1 env retroviral element involved in placentation. Mol Biol Evol 21:10 (2004), 1895–1901.
144. 144 Malassine, A., Handschuh, K., Tsatsaris, V., et al. Expression of HERV-W Env glycoprotein (syncytin) in the extravillous trophoblast of first trimester human placenta. Placenta 26:7 (2005), 556–562, 10.1016/j.placenta.2004.09.002.
145. 145 Muir, A., Human endogenous retrovirus-W envelope (syncytin) is expressed in both villous and extravillous trophoblast populations. J Gen Virol 87:7 (2006), 2067–2071, 10.1099/vir.0.81412-0.
146. 146 Soygur, B., Moore, H., Expression of Syncytin 1 (HERV-W), in the preimplantation human blastocyst, embryonic stem cells and trophoblast cells derived in vitro. Hum Reprod 31 (2016), 1455–1461, 10.1093/humrep/dew097.
147. 147 Dunlap, K.A., Palmarini, M., Varela, M., et al. Endogenous retroviruses regulate periimplantation placental growth and differentiation. Proc Natl Acad Sci USA 103:39 (2006), 14390–14395, 10.1073/pnas.0603836103.
148. 148 Cianciolo, G.J., Copeland, T.D., Oroszlan, S., Snyderman, R., Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230:4724 (1985), 453–455.
149. 149 Rasko, J.E., Battini, J.L., Gottschalk, R.J., Mazo, I., Miller, A.D., The RD114/simian type D retrovirus receptor is a neutral amino acid transporter. Proc Natl Acad Sci USA 96:5 (1999), 2129–2134.
150. 150 Chang, W.K., Yang, K.D., Shaio, M.F., Effect of glutamine on Th1 and Th2 cytokine responses of human peripheral blood mononuclear cells. Clin Immunol 93:3 (1999), 294–301, 10.1006/clim.1999.4788.
151. 151 Hummel, J., Kämmerer, U., Müller, N., Avota, E., Schneider-Schaulies, S., Human endogenous retrovirus envelope proteins target dendritic cells to suppress T-cell activation. Eur J Immunol 45:6 (2015), 1748–1759, 10.1002/eji.201445366.
152. 152 Rolland, A., Jouvin-Marche, E., Viret, C., Faure, M., Perron, H., Marche, P.N., The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses. J Immunol 176:12 (2006), 7636–7644 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=16751411.
153. 153 Bolze, P.-A., Patrier, S., Cheynet, V., et al. Expression patterns of ERVWE1/Syncytin-1 and other placentally expressed human endogenous retroviruses along the malignant transformation process of hydatidiform moles. Placenta 39 (2016), 116–124, 10.1016/j.placenta.2016.01.011.
154. 154 Holder, B.S., Tower, C.L., Abrahams, V.M., Aplin, J.D., Syncytin 1 in the human placenta. Placenta 33:6 (2012), 460–466, 10.1016/j.placenta.2012.02.012.
155. 155 Strissel, P.L., Ruebner, M., Thiel, F., et al. Reactivation of codogenic endogenous retroviral (ERV) envelope genes in human endometrial carcinoma and prestages: emergence of new molecular targets. Oncotarget 3:10 (2012), 1204–1219, 10.18632/oncotarget.679.
156. 156 Loane, M., Morris, J.K., Addor, M.-C., et al. Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening. Eur J Hum Genet 21:1 (2012), 27–33, 10.1038/ejhg.2012.94.
157. 157 Roberts, L., Sebire, N.J., Fowler, D., Nicolaides, K.H., Histomorphological features of chorionic villi at 10–14 weeks of gestation in trisomic and chromosomally normal pregnancies. Placenta 21:7 (2000), 678–683, 10.1053/plac.2000.0553.
158. 158 Frendo, J.L., Vidaud, M., Guibourdenche, J., et al. Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome. J Clin Endocrinol Metabol 85:10 (2000), 3700–3707, 10.1210/jcem.85.10.6915.
159. 159 Massin, N., Frendo, J.L., Guibourdenche, J., et al. Defect of syncytiotrophoblast formation and human chorionic gonadotropin expression in Down's syndrome. Placenta 22:suppl A (2001), S93–S97, 10.1053/plac.2001.0658.
160. 160 Malassiné, A., Pidoux, G., Gerbaud, P., Frendo, J.-L., Evain-Brion, D., Human trophoblast in trisomy 21: a model for cell-cell fusion dynamic investigation. Adv Exp Med Biol 714:chapter 4 (2011), 103–112, 10.1007/978-94-007-0782-5_4.
161. 161 Pidoux, G., Gerbaud, P., Laurendeau, I., et al. Large variability of trophoblast gene expression within and between human normal term Placentae. Placenta 25:5 (2004), 469–473, 10.1016/j.placenta.2003.10.016.
162. 162 Frendo, J.L., Guibourdenche, J., Pidoux, G., et al. Trophoblast production of a weakly bioactive human chorionic gonadotropin in trisomy 21-affected pregnancy. J Clin Endocrinol Metabol 89:2 (2004), 727–732, 10.1210/jc.2003-030668.
163. 163 Roberts, C.L., Ford, J.B., Algert, C.S., et al. Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open, 1(1), 2011, e000101, 10.1136/bmjopen-2011-000101.
164. 164 Benirschke, K., Remarkable placenta. Clin Anat 11:3 (1998), 194–205, 10.1002/(SICI)1098-2353(1998)11:3<194::AID-CA8>3.0.CO;2-T.
165. 165 Devisme, L., Merlot, B., Ego, A., Houfflin-Debarge, V., Deruelle, P., Subtil, D., A case–control study of placental lesions associated with pre-eclampsia. Int J Gynaecol Obstet 120:2 (2013), 165–168, 10.1016/j.ijgo.2012.08.023.
166. 166 Knerr, I., Beinder, E., Rascher, W., Syncytin, a novel human endogenous retroviral gene in human placenta: evidence for its dysregulation in preeclampsia and HELLP syndrome. Am J Obstet Gynecol 186:2 (2002), 210–213, 10.1067/mob.2002.119636.
167. 167 Kudo, Y., Boyd, C.A., Sargent, I.L., Redman, C.W., Hypoxia alters expression and function of syncytin and its receptor during trophoblast cell fusion of human placental BeWo cells: implications for impaired trophoblast syncytialisation in pre-eclampsia. Biochim Biophys Acta 1638:1 (2003), 63–71.
168. 168 Bainbridge, S.A., Minhas, A., Whiteley, K.J., Qu, D., Effects of reduced Gcm1 expression on trophoblast morphology, fetoplacental vascularity, and pregnancy outcomes in mice. Hypertension 59:3 (2012), 732–739, 10.1161/HYPERTENSIONAHA.111.183939/-/DC1.
169. 169 Chiang, M.-H., Liang, F.-Y., Chen, C.-P., et al. Mechanism of hypoxia-induced GCM1 degradation: implications for the pathogenesis of preeclampsia. J Biol Chem 284:26 (2009), 17411–17419, 10.1074/jbc.M109.016170.
170. 170 Zhuang, X.-W., Li, J., Brost, B.C., et al. Decreased expression and altered methylation of syncytin-1 gene in human placentas associated with preeclampsia. Curr Pharm Des 20:11 (2014), 1796–1802.
171. 171 Gao, Y., He, Z., Wang, Z., et al. Increased expression and altered methylation of HERVWE1 in the human placentas of smaller fetuses from monozygotic, dichorionic, discordant twins. PLoS One, 7(3), 2012, e33503, 10.1371/journal.pone.0033503.t004.
172. 172 Ruebner, M., Strissel, P.L., Langbein, M., et al. Impaired cell fusion and differentiation in placentae from patients with intrauterine growth restriction correlate with reduced levels of HERV envelope genes. J Mol Med (Berl) 88:11 (2010), 1143–1156, 10.1007/s00109-010-0656-8.
173. 173 Doridot, L., Passet, B., Méhats, C., Rigourd, V., Preeclampsia-like symptoms induced in mice by fetoplacental expression of STOX1 are reversed by aspirin treatment. Hypertension 61 (2013), 662–668, 10.1161/HYPERTENSIONAHA.111.202994/-/DC1.
174. 174 Rigourd, V., Chauvet, C., Chelbi, S.T., et al. STOX1 overexpression in choriocarcinoma cells mimics transcriptional alterations observed in preeclamptic placentas. PLoS One 3:12 (2008), e3905–e3909, 10.1371/journal.pone.0003905.
175. 175 Lazennec, G., Canaple, L., Saugy, D., Wahli, W., Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators. Mol Endocrinol 14:12 (2000), 1962–1975, 10.1210/mend.14.12.0575.
176. 176 Lebovic, D.I., Kavoussi, S.K., Lee, J., Banu, S.K., Arosh, J.A., PPARγ activation inhibits growth and survival of human endometriotic cells by suppressing estrogen biosynthesis and PGE2 signaling. Endocrinology 154:12 (2013), 4803–4813, 10.1210/en.2013-1168.
177. 177 Sidell, N., Han, S.W., Parthasarathy, S., Regulation and modulation of abnormal immune responses in endometriosis. Ann N Y Acad Sci 955 (2002), 159–173 Discussion 199–200, 396–406.
178. 178 Shaarawy, M., Meleigy El, M., Rasheed, K., Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome. J Soc Gynecol Investig 8:1 (2001), 27–31.
179. 179 Xu, J., Sivasubramaniyam, T., Yinon, Y., et al. Aberrant TGFβ signaling contributes to altered trophoblast differentiation in preeclampsia. Endocrinology 157:2 (2016), 883–899, 10.1210/en.2015-1696.
180. 180 Priscakova, P., Konkolova, J., Petrovic, R., et al. ERVW-1 gene polymorphisms related to preeclampsia. Bratisl Lek Listy 117:06 (2016), 340–344, 10.4149/BLL_2016_067.
181. 181 Mondestin, M.A.J., Ananth, C.V., Smulian, J.C., Vintzileos, A.M., Birth weight and fetal death in the United States: the effect of maternal diabetes during pregnancy. Am J Obstet Gynecol 187:4 (2002), 922–926.
182. 182 Cheng, X., Chapple, S.J., Patel, B., et al. Gestational diabetes mellitus impairs Nrf2-mediated adaptive antioxidant defenses and redox signaling in fetal endothelial cells in utero. Diabetes 62:12 (2013), 4088–4097, 10.2337/db13-0169.
183. 183 Hajj El, N., Pliushch, G., Schneider, E., et al. Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus. Diabetes 62:4 (2013), 1320–1328, 10.2337/db12-0289.
184. 184 Ruchat, S.-M., Houde, A.-A., Voisin, G., et al. Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases. Epigenetics 8:9 (2013), 935–943, 10.4161/epi.25578.
185. 185 West, N.A., Kechris, K., Dabelea, D., Exposure to maternal diabetes in utero and DNA methylation patterns in the offspring. Immunometabolism 1 (2013), 1–9, 10.2478/immun-2013-0001.
186. 186 Benirschke, K., Burton, G.J., Baergen, R.N., Pathology of the Human Placenta. 2012, Springer, New York, NY, 959.
187. 187 Soygur, B., Sati, L., Demir, R., Altered expression of human endogenous retroviruses syncytin-1, syncytin-2 and their receptors in human normal and gestational diabetic placenta. Histol Histopathol 31 (2016), 1037–1047, 10.14670/HH-11-735.
188. 188 Lurain, J.R., Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol 203:6 (2010), 531–539, 10.1016/j.ajog.2010.06.073.
189. 189 Lurain, J.R., Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol 204:1 (2011), 11–18, 10.1016/j.ajog.2010.06.072.
190. 190 Seckl, M.J., Sebire, N.J., Berkowitz, R.S., Gestational trophoblastic disease. Lancet 376:9742 (2010), 717–729.
191. 191 Bolze, P.-A., Riedl, C., Massardier, J., et al. Mortality of gestational trophoblastic neoplasia with a FIGO score of 13 and higher. Am J Obstet Gynecol, 214(3), 2016, 390, 10.1016/j.ajog.2015.09.083.
192. 192 Bolze, P.-A., Attia, J., Massardier, J., et al. Formalised consensus of the European Organisation for treatment of trophoblastic diseases on management of gestational trophoblastic diseases. Eur J Cancer 51:13 (2015), 1725–1731, 10.1016/j.ejca.2015.05.026.
193. 193 Judson, H., Hayward, B.E., Sheridan, E., Bonthron, D.T., A global disorder of imprinting in the human female germ line. Nature 416:6880 (2002), 539–542, 10.1038/416539a.
194. 194 Oppelt, P., Strick, R., Strissel, P.L., Winzierl, K., Beckmann, M.W., Renner, S.P., Expression of the human endogenous retroviruse-W envelope gene syncytin in endometriosis lesions. Gynecol Endocrinol 25:11 (2009), 741–747, 10.3109/09513590903184142.
195. 195 Zhou, H., Li, J., Podratz, K.C., et al. Hypomethylation and activation of syncytin-1 gene in endometriotic tissue. Curr Pharm Des 20:11 (2014), 1786–1795.
196. 196 Hu, L., Hornung, D., Kurek, R., et al. Expression of human endogenous gammaretroviral sequences in endometriosis and ovarian cancer. AIDS Res Hum Retrovirus 22:6 (2006), 551–557, 10.1089/aid.2006.22.551.
197. 197 Wang-Johanning, F., Liu, J., Rycaj, K., et al. Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer. Int J Cancer 120:1 (2006), 81–90, 10.1002/ijc.22256.
198. 198 Arimi, M.M., Nyachieo, A., Langat, D.K., Abdi, A.M., Mwenda, J.M., Evidence for expression of endogenous retroviral sequences on primate reproductive tissues and detection of cross-reactive ERVS antigens in the baboon ovary: a review. East Afr Med J 83:2 (2006), 106–112.
199. 199 Köhler, G., Milstein, C., Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:5517 (1975), 495–497.
200. 200 Pawelek, J.M., Tumour-cell fusion as a source of myeloid traits in cancer. Lancet Oncol 6:12 (2005), 988–993, 10.1016/S1470-2045(05)70466-6.
201. 201 Larizza, L., Schirrmacher, V., Graf, L., Pflüger, E., Peres-Martinez, M., Stöhr, M., Suggestive evidence that the highly metastatic variant ESb of the T-cell lymphoma Eb is derived from spontaneous fusion with a host macrophage. Int J Cancer 34:5 (1984), 699–707.
202. 202 Munzarova, M., Lauerova, L., Capkova, J., Are advanced malignant melanoma cells hybrids between melanocytes and macrophages?. Melanoma Res 2:2 (1992), 127–129.
203. 203 Larsson, L.-I., Holck, S., Christensen, I.J., Prognostic role of syncytin expression in breast cancer. Hum Pathol 38:5 (2007), 726–731, 10.1016/j.humpath.2006.10.018.
204. 204 Schiavetti, F., Thonnard, J., Colau, D., Boon, T., Coulie, P.G., A human endogenous retroviral sequence encoding an antigen recognized on melanoma by cytolytic T lymphocytes. Cancer Res 62:19 (2002), 5510–5516.
205. 205 Grow, E.J., Flynn, R.A., Chavez, S.L., et al. Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells. Nature 522:7555 (2015), 221–225, 10.1038/nature14308.
206. 206 Santoni, F.A., Guerra, J., Luban, J., HERV-H RNA is abundant in human embryonic stem cells and a precise marker for pluripotency. Retrovirology, 9(1), 2012, 111, 10.1186/1742-4690-9-111.
207. 207 Zeng, M., Hu, Z., Shi, X., et al. MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses. Science 346:6216 (2014), 1486–1492, 10.1126/science.346.6216.1486.
208. 208 Strick, R., Strissel, P.L., Baylin, S.B., Chiappinelli, K.B., Unraveling the molecular pathways of DNA-methylation inhibitors: human endogenous retroviruses induce the innate immune response in tumors. Oncoimmunology, 5, 2016, e1122160, 10.1080/2162402X.2015.1122160.
209. 209 Kassiotis, G., Stoye, J.P., Immune responses to endogenous retroelements: taking the bad with the good. Nat Publ Group 16:4 (2016), 207–219, 10.1038/nri.2016.27.
210. 210 Armando, R.G., Gomez, D.M., Gomez, D.E., AZT exerts its antitumoral effect by telomeric and non-telomeric effects in a mammary adenocarcinoma model. Oncol Rep 36:5 (2016), 2731–2736, 10.3892/or.2016.5094.